Mr. Andrew Dodson

Mr. Andrew Dodson


  • Director, UK NEQAS Immunocytochemistry and In Situ Hybridisation (ICC & ISH). Member of the Board of Assessors since 1995: became Deputy Director for the Scheme in 2007.
  • Executive Board representative for ICC & ISH and Divisional Representative for Cellular Pathology Division.


  • Worked within the NHS since 1981, qualifying as a Biomedical Scientist in Histopathology while working at St. George's Hospital in London in 1984
  • Moved to Liverpool in 1990 and ran the Immunocytochemistry service and latterly the Molecular Pathology service at the Royal Liverpool University Hospital until 2013
  • Returned to London to take up a role as a Senior Research Clinical Scientist in the Breast Cancer Research Unit at the Royal Marsden Hospital
  • Took post as Deputy Director UK NEQAS Immunocytochemistry and In Situ Hybridisation (ICC & ISH) in 2007. At the end of 2018, was appointed as its Director.


  •  Postgraduate course author and tutor for University of Greenwich ICC and diagnostic breast cancer courses
  •  Chair of Institute of Biomedical Science (IBMS) ICC Diploma of Expert Practice Working Group
  •  Member of IBMS Scientific Advisory Panel for Cellular Pathology